Pfizer attracts Verily’s first chief marketing officer


Pfizer is hiring an Alphabet life sciences executive as its first global chief marketing officer, the third major addition to its senior ranks this year.

Drew Panayiotou, chief marketing officer of Alphabet Verily’s life sciences research arm, will join Pfizer on September 19. He will be responsible for building a business infrastructure that includes “new, innovative engagement channels, tools and digital solutions,” Pfizer said in an emailed statement. . He will report to Angela Hwang, head of Pfizer’s biopharmaceutical unit.

The announcement comes about six months after two retirements prompted a reshuffle of Pfizer’s top ranks, amid revenue rising to record highs from sales of its COVID-19 vaccine and antiviral drug. . Pfizer hired William Pao as Roche’s chief development officer in February and David Denton as Lowe’s chief financial officer in April.

Pfizer knows Verily from a partnership it, along with three other pharmaceutical companies, signed with the technology company in 2019 to leverage its data tools for clinical studies.

Panayiotou was also Verily’s first marketing director. He has over 30 years of marketing experience, having previously worked at Johnson & Johnson, Coca-Cola and Disney, among others. At Pfizer, he joins a company whose business dwarfs most others in the pharmaceutical sector, after its first-half revenue jumped 60% and is on track to hit around $100 billion for the first time.

“Drew’s insights and diverse thinking will help us elevate the customer channels, cutting-edge skills and capabilities we need to deliver” new medicines to patients, Hwang said in a post on LinkedIn.


Comments are closed.